लिक्विड मेथोट्रेक्सेट इंजेक्शन

89.19

इंजेक्शन

WHO GMP

WHO-GMP, ISO 9001:2015

कैश इन एडवांस (CID)

अफ्रीका

As per Order

Methotrexate injection 20ml is packed in a bottle and customized packaging is also available.

Store it at room temperature

Dry And Cool Place

Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function.

osteoporosis

2ml per bottle

1 VIAL

India

India

Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function.

Denosurel 120mg Injection contains Denosumab, a targeted medication used to strengthen bones and prevent bone-related complications in patients with osteoporosis, multiple myeloma, and cancers that have spread to the bones (bone metastases). It works by blocking RANK ligand, a protein involved in bone breakdown, helping to reduce bone loss, increase bone density, and lower the risk of fractures. Clinical studies have shown that Denosumab can significantly improve bone strength in postmenopausal women with osteoporosis and individuals experiencing cancer-related bone loss. Patients receiving Denosurel 120mg Injection should ensure adequate calcium and vitamin D intake throughout treatment to support healthy bone metabolism and reduce the risk of low calcium levels. Individuals with moderate kidney impairment may require regular monitoring of renal function during therapy. This medication should not be used by patients with a known allergy to Denosumab or any of its ingredients and should be administered with caution in those with pre-existing hypoparathyroidism. As the safety and effectiveness of Denosurel 120mg Injection have not been established in children and adolescents, it is not recommended for individuals under 18 years of age. When used under medical supervision, Denosurel 120mg Injection can play an important role in protecting bone health and preventing serious skeletal complications.